Manitoba getting 1,100 doses of newly approved COVID-19 antiviral treatment
Manitoba will be getting 1,100 doses of the Pfizer COVID-19 antiviral treatment called Paxlovid.
A tweet from the Manitoba Government account on Monday said this is an initial allotment and more doses have been requested.
On Monday, Health Canada announced the approval of the drug, which is the first COVID-19 therapy that can be taken at home.
Dr. Supriya Sharma, the chief medical adviser of Health Canada, said the treatment consists of two drugs that are taken together twice per day, for five days. It is only for use after the diagnosis of COVID-19 and must be given within five days of the start of symptoms.
She added the studies submitted by Pfizer for Health Canada to review showed an effectiveness at preventing severe outcomes like hospitalization and death caused by COVID-19 by close to 90 per cent when taken within three days of symptoms showing up. The effectiveness is reduced slightly when taken five days after symptom onset to 85 per cent.
“I’ve never really liked the term game changer, but this is a really important tool that I think will provide some relief to hospitals,” said Dr. Philippe Lagacé-Wiens, a medical microbiologist at St. Boniface Hospital. “But there are a lot of warnings and caveats that come with that.”
Lagacé-Wiens said because initial supply is so limited, the impact won’t be huge on hospitals. He said it is also not a replacement for vaccination. He said the province needs to get to the point where the drug is widely available and easy to access through community pharmacies.
“At that point, for the high-risk people, it probably will make a major difference," he said. "But until we get to a really good supply chain and a testing system that works, we’re not going to see a huge difference. But it’s still really good news if you think about it.”
Lagacé-Wiens also said that because a confirmed positive test is needed to get Paxlovid, testing may need to be prioritized for people at higher risk of hospitalization and death since getting the drug early is so important.
“So this is really a great tool, but it has to be applied to the community setting in mild to moderate COVID-19 to reduce hospitalizations,” he said. “We really need to have excellent access to testing to be able to identify those people who are going to benefit from it, the ones with those risk factors we have been hearing over and over again in the pandemic because those are the ones who will benefit the most.”
Lagacé-Wiens said these populations may include people over 60, those with diabetes or lung disease or who are overweight. He also said this treatment is not approved for everyone, as children and pregnant women are not eligible. Paxlovid also has many medications that it interacts with, like birth control to antidepressants and more.
There is no word on when the first shipment of Paxlovid will arrive in Manitoba or how it will be distributed.
CTVNews.ca Top Stories
MPP Sarah Jama asked to leave Ontario legislature for wearing keffiyeh
MPP Sarah Jama was asked to leave the Legislative Assembly of Ontario by House Speaker Ted Arnott on Thursday for wearing a keffiyeh, a garment which has been banned at Queen’s Park.
Mountain guide dies after falling into a crevasse in Banff National Park
A man who fell into a crevasse while leading a backcountry ski group deep in the Canadian Rockies has died.
2 teens charged in Halifax homicide: police
Two teenagers have been charged with second-degree murder in connection to an alleged homicide near the Halifax Shopping Centre earlier this week.
'Deep ignorance': Calls for Manitoba trustee to resign sparked after comments about Indigenous people and reconciliation
A rural Manitoba school trustee is facing calls to resign over comments he made about Indigenous people and residential schools earlier this week.
ByteDance prefers TikTok shutdown in U.S. if legal options fail, Reuters sources say
TikTok owner ByteDance would prefer to shut down its loss-making app rather than sell it if the Chinese company exhausts all legal options to fight legislation to ban the platform from app stores in the U.S., four sources said.
12-year-old hippo in Japan raised as a male discovered to be a female
When Gen-chan arrived at a zoo in Japan in 2017, no one questioned whether the then-five-year-old hippopotamus was a boy. Seven years later, zoo staff made a surprising discovery: Gen-chan, now 12, was female.
Here's why Harvey Weinstein's New York rape conviction was tossed and what happens next
Here's what you need to know about why movie mogul Harvey Weinstein's rape conviction was thrown out and what happens next.
Improve balance and build core strength with this exercise
When it comes to cardiovascular fitness, you may tend to focus on activities that move you forward, such as walking, running and cycling.
Legendary hockey broadcaster Bob Cole dies at 90: CBC
Bob Cole, a welcome voice for Canadian hockey fans for a half-century, has died at the age of 90. Cole died Wednesday night in St. John's, N.L., surrounded by his family, his daughter, Megan Cole, told the CBC.